Oncolytics Biotech Brief: Announcing "Key Progress" and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Preparing for FDA Accelerated Approval Path
Oncolytics Biotech Brief: Announcing "Key Progress" and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Preparing for FDA Accelerated Approval Path
oncolytics biotech简报：宣布乳腺癌和胰腺癌治疗的"关键进展"和即将开展的研究，为获得FDA加速批准路径做准备
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册